Stryker Corp.
SYK
Market Cap$126.04B
Close$
Earnings Call Q4 2023
January 30, 2024 - AI Summary
Stryker reported strong Q4 and full-year 2023 results, with sales growth of over 11% for both periods.
The company expects to continue delivering high sales growth in 2024, with organic sales growth projected to be between 7.5% and 9%.
Stryker's focus on innovation and acquisitions will drive future growth, with a pipeline of new product launches planned for 2024.
Exclusive for Stockcircle Pro members
Sign up
$197.37
40.3% downside
Current Fair Value
40.3% downsideOvervalued by 40.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $126.04 Billion |
|---|---|
| Enterprise Value | $136.50 Billion |
| Dividend Yield | $3.0886 (0.93%) |
| Earnings per Share | $8.75 |
| Beta | 0.71 |
| Outstanding Shares | 380,949,778 |
| Avg 30 Day Volume | 1,527,345 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 37.5 |
|---|---|
| PEG | 113.27 |
| Price to Sales | 6.01 |
| Price to Book Ratio | 6.61 |
| Enterprise Value to Revenue | 6.51 |
| Enterprise Value to EBIT | 32.95 |
| Enterprise Value to Net Income | 40 |
| Total Debt to Enterprise | 0.09 |
| Debt to Equity | 0.67 |
Revenue Sources
No data
ESG Score
No data
About Stryker Corp.
40,000 employees
CEO: Kevin Lobo Stryker is one of the world's leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neur...